TrialThe journal of headache and pain2021

Treatment benefit among migraine patients taking fremanezumab: results from a post hoc responder analysis of two placebo-controlled trials.

Stephen D Silberstein et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.